X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (12) 12
mrp4 (8) 8
multidrug resistance (8) 8
multidrug resistance-associated proteins - metabolism (7) 7
pharmacology & pharmacy (7) 7
proteins (7) 7
animals (6) 6
atp-binding cassette transporters - metabolism (6) 6
drug resistance in microorganisms (6) 6
efflux (6) 6
bcrp (5) 5
breast cancer (5) 5
neoplasm proteins - metabolism (5) 5
physiological aspects (5) 5
biochemistry & molecular biology (4) 4
cancer (4) 4
inhibition (4) 4
mrp4/abcc4 (4) 4
multidrug resistance-associated proteins - genetics (4) 4
p-glycoprotein (4) 4
transporter (4) 4
abcc4 (3) 3
atp binding cassette transporter, sub-family g, member 2 (3) 3
development and progression (3) 3
drug interactions (3) 3
drug resistance (3) 3
excretion (3) 3
in-vitro (3) 3
oncology (3) 3
transfection (3) 3
transport (3) 3
4 mrp4/abcc4 (2) 2
abc transporters (2) 2
abcg2 (2) 2
acid (2) 2
acids (2) 2
ae2, anion exchanger 2 (2) 2
antiviral agents - pharmacokinetics (2) 2
atp-binding cassette transporters - genetics (2) 2
atp-binding cassette, sub-family b, member 1 - metabolism (2) 2
beta (2) 2
bile acids and salts - metabolism (2) 2
biological transport (2) 2
biological transport - drug effects (2) 2
bsep, bile salt export pump (2) 2
carrier proteins (2) 2
carrier proteins - metabolism (2) 2
ceefourin (2) 2
cell line (2) 2
cholestasis (2) 2
chronic kidney failure (2) 2
confers resistance (2) 2
cytotoxicity (2) 2
dose-response relationship, drug (2) 2
drugs (2) 2
efflux transporters (2) 2
entecavir (2) 2
expression (2) 2
familial intrahepatic cholestasis (2) 2
farnesoid-x-receptor (2) 2
fxr, farnesoid x receptor (2) 2
gene expression (2) 2
genetic aspects (2) 2
gr, glucocorticoid receptor (2) 2
guanine - analogs & derivatives (2) 2
guanine - pharmacokinetics (2) 2
health aspects (2) 2
hep g2 cells (2) 2
hepatitis b - drug therapy (2) 2
hepatocytes - metabolism (2) 2
high-throughput screening (2) 2
hnf1α, hepatocyte nuclear factor 1 alpha (2) 2
hnf4α, hepatocyte nuclear factor 4 alpha (2) 2
icp, intrahepatic cholestasis of pregnancy (2) 2
inhibitors (2) 2
interplay (2) 2
intracellular (2) 2
kidney (2) 2
kidneys (2) 2
kynurenic acid (2) 2
lamivudine (2) 2
liver - metabolism (2) 2
medicine (2) 2
medicine, research & experimental (2) 2
membrane transport proteins - genetics (2) 2
metabolism (2) 2
metabolites (2) 2
methotrexate (2) 2
molecular biology (2) 2
molecular medicine (2) 2
mrp protein (2) 2
mrp4 inhibitor (2) 2
multidrug resistance-associated proteins - antagonists & inhibitors (2) 2
multidrug-resistance (2) 2
neoplasm proteins - genetics (2) 2
organic anion transporters (2) 2
patients (2) 2
pbc, primary biliary cirrhosis (2) 2
permeability (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 08/2017, Volume 106, pp. 313 - 327
Journal Article
Food and Function, ISSN 2042-6496, 03/2018, Volume 9, Issue 3, pp. 1410 - 1423
Active efflux transport of glucuronides out of cells is a critical process in elimination of drugs and food derived compounds. Wushanicaritin, a natural... 
PERFORMANCE LIQUID-CHROMATOGRAPHY | IN-VITRO | INTERPLAY | UDP-GLUCURONOSYLTRANSFERASES | VIVO | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOOD SCIENCE & TECHNOLOGY | OVEREXPRESSING SULT1A3 | FLAVONOIDS | DRUG-METABOLISM REACTIONS | 4 MRP4/ABCC4 | MASS-SPECTROMETRY | Propionates - pharmacology | RNA, Small Interfering - genetics | Epimedium - chemistry | Humans | Drugs, Chinese Herbal - pharmacology | Neoplasm Proteins - metabolism | Drugs, Chinese Herbal - metabolism | ATP Binding Cassette Transporter, Sub-Family G, Member 2 - metabolism | Heterocyclic Compounds, 4 or More Rings - pharmacology | Quinolines - pharmacology | Gene Knockdown Techniques | Glucuronosyltransferase - genetics | Glucuronides - metabolism | Dipyridamole - pharmacology | Multidrug Resistance-Associated Proteins - genetics | Biological Transport - drug effects | Flavonoids - pharmacology | Neoplasm Proteins - genetics | Gene Silencing | Diketopiperazines - pharmacology | ATP Binding Cassette Transporter, Sub-Family G, Member 2 - genetics | Glucuronosyltransferase - metabolism | Flavonoids - metabolism | HeLa Cells | Multidrug Resistance-Associated Proteins - metabolism | RNA, Small Interfering - metabolism | Efflux | Excretion | MRP protein | Multidrug resistance | Dipyridamole | Breast cancer | Ribonucleic acid--RNA | Proteins | Gene silencing | Reduction | Inhibitors | Transfection | Inhibition | Intracellular | Transporter | Cancer
Journal Article
Biopharmaceutics & Drug Disposition, ISSN 0142-2782, 09/2012, Volume 33, Issue 6, pp. 304 - 315
The inhibition potencies of aripiprazole and its active metabolite, dehydroaripiprazole, on the activities of human multidrug resistance protein 1 (MDR1/ABCB1;... 
BCRP | inhibition | aripiprazole | MDR1 | MRP4 | GLYCOPROTEIN DEFICIENT MICE | MULTIDRUG TRANSPORTER | P-GLYCOPROTEIN | IN-VITRO | PHARMACOKINETICS | DIGOXIN | ANTIPSYCHOTIC-DRUGS | PHARMACOLOGY & PHARMACY | INHIBITORS | CACO-2 CELLS | CANCER RESISTANCE PROTEIN | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Intestines - drug effects | Digoxin - metabolism | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Neoplasm Proteins - antagonists & inhibitors | Piperazines - metabolism | Intestines - metabolism | Quinolones - pharmacology | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Aripiprazole | Neoplasm Proteins - metabolism | Dose-Response Relationship, Drug | Drug Interactions | Transfection | ATP-Binding Cassette Transporters - genetics | Biotransformation | Madin Darby Canine Kidney Cells | ATP-Binding Cassette Transporters - metabolism | Multidrug Resistance-Associated Proteins - genetics | Neoplasm Proteins - genetics | Quinolones - metabolism | Multidrug Resistance-Associated Proteins - antagonists & inhibitors | Permeability | Blood-Brain Barrier - drug effects | Piperazines - pharmacology | Blood-Brain Barrier - metabolism | Animals | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Models, Biological | Dogs | Antipsychotic Agents - metabolism | ATP Binding Cassette Transporter, Sub-Family B | Antipsychotic Agents - pharmacology | Multidrug Resistance-Associated Proteins - metabolism | ATP-Binding Cassette Transporters - antagonists & inhibitors | Care and treatment | Antipsychotic drugs | Metabolites | Drug resistance | Cancer
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 1, pp. 155 - 168
Summary Bile acid (BA) transporters are critical for maintenance of the enterohepatic BA circulation where BAs exert their multiple physiological functions... 
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | RAT-LIVER | SALT EXPORT PUMP | GROWTH-FACTOR 19 | ORGANIC ANION TRANSPORTERS | 90-PERCENT PARTIAL-HEPATECTOMY | URSODEOXYCHOLIC ACID | PRIMARY BILIARY-CIRRHOSIS | FARNESOID-X-RECEPTOR | GASTROENTEROLOGY & HEPATOLOGY | PHOSPHOLIPID-ASSOCIATED CHOLELITHIASIS | FAMILIAL INTRAHEPATIC CHOLESTASIS | Animals | Carrier Proteins - metabolism | Cholestasis - metabolism | Membrane Glycoproteins - metabolism | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Liver Diseases - metabolism | Liver Regeneration - physiology | Receptors, Cytoplasmic and Nuclear - metabolism | Drug resistance in microorganisms | Corticosteroids | Glucagon | Calcifediol | Ursodiol | Deoxycholic acid | Epidermal growth factor | Vitamin D | Physiological aspects | Fibroblast growth factors | Alfacalcidol | IBABP (FABP6, ILBP), intestinal bile acid-binding protein, fatty acid-binding protein 6 | PFIC, progressive familial intrahepatic cholestasis | TNFα, tumor necrosis factor α | 3 (human) | SRC2, p160 steroid receptor coactivator | NAFLD, non-alcoholic fatty liver disease | BA, bile acid | bile acid receptor | 8, cholesterol efflux pump, ATP-binding cassette, subfamily G, member 5 | UDCA, ursodeoxycholic acid | LRH-1 (NR5A2), liver receptor homolog-1 | LCA, lithocholic acid | LXRα (NR1H3), liver X receptor alpha | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | OSTαβ, organic solute transporter alpha | ABCG5 | AMPK, AMP activated protein kinase | NASH, non-alcoholic steatohepatitis | SHP (NR0B2), short heterodimer partner | OATP1A2 (SLCO1A2, OATP1, OATP-A, SLC21A3), solute carrier organic anion transporter family, member 1A2 | EGFR, epidermal growth factor receptor | IL6, interleukin 6 | TGR5, G protein-coupled bile acid receptor | PH, partial hepatectomy | AE2, anion exchanger 2 | PSC, primary sclerosing cholangitis | OATP1B1 (SLCO1B1, OATP2, OATP-C, SLC21A6), solute carrier organic anion transporter family, member 1B1 | RARα (NR1B1), retinoic acid receptor alpha | GLP-1, glucagon like peptide 1 | VDR (NR1I1), vitamin D receptor. Please note that for the convenience of better readability and clarity, abbreviations for transporters and nuclear receptors were capitalized throughout this article when symbols were identical for human and rodents | MRP2 (ABCC2), multidrug resistance-associated protein 2, ATP-binding cassette, subfamily C, member 2 | NTCP (SLC10A1), sodium | CAR (NR1I3), constitutive androstane receptor | taurocholate cotransporting polypeptide, solute carrier family 10, member 1 | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | GR (NR3C1), glucocorticoid receptor | Bile acids, Cholestasis, Fatty liver disease, Gallstones, Liver regeneration, Liver cancer | 19, fibroblast growth factor 15 | Mdr2 | ICP, intrahepatic cholestasis of pregnancy | BRIC, benign recurrent intrahepatic cholestasis | OATP1B3 (SLCO1B3, OATP8, SLC21A8), solute carrier organic anion transporter family, member 1B3 | MRP3 (ABCC3), multidrug resistance-associated protein 3, ATP-binding cassette, subfamily C, member 3 | beta | MDR1 (ABCB1), p-glycoprotein, ATP-binding cassette, subfamily B, member 1 | norUDCA, norursodeoxycholic acid | 6-ECDCA, 6-ethylchenodeoxycholic acid | FXR (NR1H4), farnesoid X receptor | BCRP (ABCG2), breast cancer resistance protein, ATP-binding cassette, subfamily G, member 2 | HNF4α (NR2A1), hepatocyte nuclear factor 4 alpha | PBC, primary biliary cirrhosis | MDR3 (ABCB4), multidrug resistance protein 2 (rodents) | HNF1α, hepatocyte nuclear factor 1 alpha | NR, nuclear receptor | FGF15 | RXRα (NR2B1), retinoid X receptor alpha | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | HCC, hepatocellular carcinoma | MRP4 (ABCC4), multidrug resistance-associated protein 4, ATP-binding cassette, subfamily C, member 4 | TPN, total parenteral nutrition
Journal Article
Molecular Aspects of Medicine, ISSN 0098-2997, 06/2014, Volume 37, Issue 100, pp. 57 - 76
Hepatobiliary bile salt (BS) transporters are critical determinants of BS homeostasis controlling intracellular concentrations of BSs and their enterohepatic... 
Nuclear receptors | ATB-binding cassette transporters | Cholestasis | ORGANIC-SOLUTE-TRANSPORTER | MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | VITAMIN-D-RECEPTOR | NA+/TAUROCHOLATE-COTRANSPORTING POLYPEPTIDE | ORPHAN NUCLEAR RECEPTOR | EXPORT PUMP BSEP | CONSTITUTIVE ANDROSTANE RECEPTOR | PRIMARY BILIARY-CIRRHOSIS | ALPHA-OST-BETA | FARNESOID-X-RECEPTOR | FAMILIAL INTRAHEPATIC CHOLESTASIS | Cholestasis - genetics | Transcriptional Activation - genetics | Cholestasis - therapy | Humans | Gene Expression Regulation | Bile Acids and Salts - metabolism | Symporters - metabolism | Organic Anion Transporters, Sodium-Dependent - genetics | Cholestasis - pathology | ATP-Binding Cassette Transporters - genetics | Biological Transport | ATP Binding Cassette Subfamily B Member 11 | Membrane Transport Proteins - genetics | Symporters - genetics | ATP-Binding Cassette Transporters - metabolism | Membrane Transport Proteins - metabolism | Organic Anion Transporters, Sodium-Dependent - metabolism | Genetic aspects | Genetic transcription | MAF, musculo-aponeurotic fibrosacroma | TNF-α, tumor necrosis factor alpha | NDRG2, NMYC downstrean-regulated gene 2 | RARα (NR1B1), retinoic acid receptor | IL-6, interleukin 6 | ABC, ATP-binding cassette | DCA, deoxycholic acid | GGT, gamma-glutamyl transpeptidase | CARM1, co-activator-associated arginine methyltransferase 1 | SRC2, steroid receptor co-activator 2 | TCDCA, taurochenodeoxycholic acid | MRP2 (ABCC2), multidrug resistance-associated protein 2 | SREBP1, sterol regulatory element-binding protein 1 | ASBT (SLC10A2), apical sodium-dependent bile acid transporter | CA, cholic acid | UDCA, ursodeoxycholic acid | FGF15, fibroblast growth factor 19 | MARE, MAF recognition element | TβMCA, β-tauromuricholic acid | VDR (NR1I1), vitamin D receptor | CBDL, common bile duct ligation | STAT-5, signal transducer and activator of transcription 5 | MCL-1, myeloid cell leukemia factor 1 | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | FXRE, FXR response element | LXR (NR1H3), liver X receptor | CtBP, C-terminal binding protein | OSTβ (SLC51A | SHP (NR0B2), short heterodimer partner | PL, phospholipid | BCRP (ABCG2), breast cancer resistance protein | TUDCA, tauroursodeoxycholic acid | OATP, organic anion transporting polypeptide | TCA, taurocholic acid | NTCP (SLC10A1), Na+-taurocholate cotransporting polypeptide solute carrier family 10 member 1 | PSC, primary sclerosing cholangitis | LRH1 (NR5A2), liver receptor homologue 1 | LPS, lipopolysaccharide | MRP3 (ABCC3), multidrug resistance-associated protein 3 | SLC51B), organic solute transporter alpha | TGR5, G protein coupled bile acid receptor | MDR2 (ABCB4), multidrug resistance protein 2 | FXR, farnesoid X receptor (NR1H4) | IR-1, inverse repeat 1 | OCA, obeticholic acid | MRP4 (ABCC4), multidrug resistance-associated protein 4 | AE2 (SLC4A2), anion exchanger 2 | NF-κB, nuclear factor kappa-B | CCl4, carbone tetrachloride | AMPK, AMP-activated protein kinase | ALP, alkaline phosphatase | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | DILI, drug-induced liver injury | JNK, c-Jun N-terminal kinase | GR (NR3C1), glucocorticoid receptor | BS, bile salt | IL-1β, interleukin-1 beta | cAMP, cyclic adenosine monophosphate | PGC-1α, peroxisome proliferator-activated receptor gamma coactivator-1 alpha | RXRα (NR2B1), retinoid X receptor | VPAC-1, vasoactive intestinal polypeptide activated receptor | ASCOM, activating signal cointegrator-2-containing complex | ICP, intrahepatic cholestasis of pregnancy | GCA, glycocholic acid | MDR1 (ABCB1), multidrug resistance protein 1 | NRF2, nuclear factor erythroid 2-related factor 2 | beta | ALT, alanine aminotransferase | LCA, litocholic acid | BRIC2, benign recurrent intrahepatic cholestasis type 2 | OSTα | CDCA, chenodeoxycholic acid | PBC, primary biliary cirrhosis | HNF1α, hepatocyte nuclear factor 1 alpha | GRE, glucocorticoid response element | TαMCA, α-tauromuricholic acid | FGF19 | PFIC2, progressive familial intrahepatic cholestasis type 2 | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | TPN, total parenteral nutrition | HNF4α, hepatocyte nuclear factor 4 alpha
Journal Article